These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8845492)

  • 21. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy].
    Derigs HG; Huber C; Mahlke M; Kolbe K
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):190-7. PubMed ID: 8682284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy of breast cancer: update.
    Cufer T
    Ann Oncol; 1999; 10 Suppl 6():129-37. PubMed ID: 10676564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose therapy for breast cancer.
    Hudis CA; Münster PN
    Semin Oncol; 1999 Feb; 26(1):35-47. PubMed ID: 10073560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy in the management of breast cancer.
    Overmoyer BA
    Cleve Clin J Med; 1995; 62(1):36-50. PubMed ID: 7859401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of dose-dense chemotherapy for breast cancer.
    Seidman AD
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Small' randomised neo-adjuvant chemotherapy trials in breast cancer reporting on pathological response: more harm than good?
    Bonnefoi H
    Ann Oncol; 2005 Sep; 16(9):1407-10. PubMed ID: 16076932
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant systemic therapy for operable breast cancer.
    Narayanan S; Taylor I
    Surgeon; 2007 Apr; 5(2):101-6; quiz 106, 121. PubMed ID: 17450692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
    Ariyoshi Y; Ogawa M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient benefits from new treatment options and schedules for breast cancer.
    Smith IE
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-22-S10-26. PubMed ID: 9275003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy can be delayed in breast cancer.
    Bagchi S
    Lancet Oncol; 2006 Nov; 7(11):892. PubMed ID: 17106953
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.
    Gianni L; Eiermann W; Semiglazov V; Lluch A; Tjulandin S; Zambetti M; Moliterni A; Vazquez F; Byakhov MJ; Lichinitser M; Climent MA; Ciruelos E; Ojeda B; Mansutti M; Bozhok A; Magazzù D; Heinzmann D; Steinseifer J; Valagussa P; Baselga J
    Lancet Oncol; 2014 May; 15(6):640-7. PubMed ID: 24657003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in systemic chemotherapy of primary breast cancer: an overview.
    Hortobagyi GN
    J Natl Cancer Inst Monogr; 2001; (30):72-9. PubMed ID: 11773296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients.
    Bertuzzi A; Gullo G; Rimassa L; Castagna L; Santoro A
    Ann Oncol; 2006 Apr; 17(4):719-20. PubMed ID: 16291584
    [No Abstract]   [Full Text] [Related]  

  • 37. High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer.
    McCauley DL
    Am J Health Syst Pharm; 1996 Mar; 53(5):521-34; quiz 561-2. PubMed ID: 8697012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?
    Castagna L; Martino M
    Bone Marrow Transplant; 2013 Feb; 48(2):305. PubMed ID: 22750999
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic treatment for stage I and stage II breast cancer.
    Hudis CA; Borgen P
    Surg Oncol Clin N Am; 1997 Oct; 6(4):683-98. PubMed ID: 9309088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.